BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
688428 InnoCare Pharma
- 20.62
- +0.71+3.57%
Market Closed May 15 15:00 CST
36.34BMarket Cap-129.69P/E (TTM)
20.83High19.91Low61.74KlotVolume20.00Open19.91Pre Close126.54MTurnover2.32%Turnover RatioLossP/E (Static)1.76BShares22.5452wk High5.39P/B5.49BFloat Cap7.2852wk Low23.89Limit Up266.28MShs Float22.54Historical High15.93Limit Down4.62%Amplitude7.28Historical Low--Dividend TTM20.50Avg Price28.33KlotAsk--Div YieldTTM100Lot Size31.79KlotBid
InnoCare Pharma Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 129.92%381.26M | 36.68%1.01B | 29.85%697.75M | 11.17%419.74M | -12.44%165.82M | 18.09%738.54M | 21.68%537.36M | 53.50%377.55M | 58.99%189.39M | -40.04%625.4M |
| Operating revenue | 129.92%381.26M | 36.68%1.01B | 29.85%697.75M | 11.17%419.74M | -12.44%165.82M | 18.09%738.54M | 21.68%537.36M | 53.50%377.55M | 58.99%189.39M | -40.04%625.4M |
| Total operating cost | 26.71%383.94M | 6.21%1.46B | -10.33%975.97M | -17.29%679.41M | 45.97%303.02M | -13.04%1.38B | -16.39%1.09B | 15.96%821.43M | -17.58%207.59M | 51.08%1.58B |
| Operating cost | 48.48%36.07M | 7.79%138.44M | -2.83%98.03M | -20.94%60.14M | -43.38%24.29M | -10.43%128.44M | 1.16%100.88M | 21.25%76.07M | 49.71%42.9M | 118.37%143.4M |
| Operating tax surcharges | 130.14%6.99M | 57.00%15.24M | 59.94%10.74M | 57.16%6.64M | 33.59%3.04M | 40.74%9.7M | 90.31%6.71M | 105.86%4.23M | 78.69%2.27M | 395.38%6.9M |
| Operating expense | 27.34%114.01M | 14.46%419.96M | 2.48%273.93M | -17.81%157.15M | 4.15%89.53M | -16.35%366.89M | -7.91%267.3M | 2.77%191.21M | -8.22%85.96M | 46.96%438.61M |
| Administration expense | 0.83%42.76M | -8.47%168.53M | -1.66%125.82M | 2.15%84.98M | 14.89%42.41M | 5.18%184.12M | 5.78%127.94M | 8.49%83.18M | 0.80%36.91M | 25.83%175.05M |
| Financial expense | 30.88%-23.49M | -36.07%-93.76M | -510.93%-147.53M | -148.23%-50.9M | 66.49%-33.98M | -140.22%-68.91M | -88.49%35.9M | 2.90%105.54M | -168.82%-101.41M | 190.69%171.32M |
| -Interest expense (Financial expense) | 161.10%13.52M | -4.02%33.79M | -32.62%20.56M | -48.77%10.47M | -50.03%5.18M | 102.58%35.21M | 378.92%30.51M | 1,186.60%20.44M | 689.65%10.36M | 459.56%17.38M |
| -Interest Income (Financial expense) | 28.38%-33.75M | 10.79%-171.59M | 3.54%-138.56M | -0.84%-94.56M | -2.15%-47.13M | -40.48%-192.33M | -53.84%-143.64M | -58.44%-93.77M | -57.28%-46.14M | -1.32%-136.91M |
| Research and development | 16.81%207.6M | 7.57%814.61M | 11.87%614.98M | 16.67%421.4M | 26.09%177.73M | 16.73%757.25M | 15.65%549.72M | 29.79%361.19M | 8.93%140.95M | -11.47%648.7M |
| Credit Impairment Loss | --239.19K | -457.68%-1.5M | -2,211.70%-683.96K | -2,182.92%-668.42K | ---- | -168.13%-268.08K | 144.03%32.39K | 137.56%32.09K | ---- | -208.09%-99.98K |
| Asset Impairment Loss | ---188.44K | ---104.96K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net revenue | ||||||||||
| Fair value change income | 115.54%2.56M | 43.55%-30.46M | -25.31%-29.42M | -50.85%-23.26M | -155.08%-16.48M | -642.18%-53.96M | -76.84%-23.48M | -80.55%-15.42M | -16.48%-6.46M | 122.48%9.95M |
| Invest income | 887.16%10.54M | 27.72%7.12M | 187.64%3.09M | 55.32%-932.69K | -88.90%-1.34M | 554.99%5.57M | 58.63%-3.53M | 74.06%-2.09M | 77.55%-709.13K | -129.11%-1.22M |
| -Including: Investment income associates | 105.89%78.94K | -7.34%-5.26M | 7.48%-3.26M | 26.42%-1.54M | -88.90%-1.34M | 49.54%-4.9M | 61.99%-3.53M | 76.28%-2.09M | 78.10%-709.13K | -1,507.46%-9.71M |
| Asset deal income | --3.4K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other revenue | -36.54%5.91M | -24.70%27.46M | -31.70%19.95M | -31.43%16.61M | -16.35%9.32M | -35.73%36.47M | -26.91%29.21M | -28.30%24.23M | -47.97%11.14M | 97.02%56.74M |
| Operating profit | 111.25%16.39M | 30.73%-451.05M | 48.02%-285.28M | 38.71%-267.92M | -923.83%-145.69M | 27.10%-651.15M | 34.82%-548.85M | 1.84%-437.12M | 88.15%-14.23M | -4,062.03%-893.2M |
| Add:Non operating Income | ---- | -97.67%274.52K | -99.58%47.82K | -99.45%46.72K | 4,957.94%31K | 14,159.31%11.78M | 119,931.91%11.48M | 88,217.86%8.44M | -38.71%612.9 | -96.83%82.63K |
| Less:Non operating expense | ---- | -62.38%1.82M | -97.15%54.41K | -89.27%54.34K | ---- | 694.97%4.83M | 214.75%1.91M | -1.30%506.68K | ---- | -52.07%608.04K |
| Total profit | 111.25%16.39M | 29.74%-452.59M | 47.10%-285.29M | 37.57%-267.92M | -923.66%-145.66M | 27.92%-644.21M | 36.00%-539.29M | 3.73%-429.18M | 88.20%-14.23M | -4,341.66%-893.73M |
| Less:Income tax cost | 9,545,052.74%1.92M | -81.57%262.75K | --28.42K | --28.45K | --20.1 | --1.43M | ---- | ---- | ---- | ---- |
| Net profit | 109.94%14.48M | 29.86%-452.86M | 47.09%-285.32M | 37.57%-267.95M | -923.66%-145.66M | 27.76%-645.63M | 36.00%-539.29M | 3.73%-429.18M | 88.20%-14.23M | -1,240.34%-893.73M |
| Net profit from continuing operation | 109.94%14.48M | 29.86%-452.86M | 47.09%-285.32M | 37.57%-267.95M | -923.66%-145.66M | 27.76%-645.63M | 36.00%-539.29M | 3.73%-429.18M | 88.20%-14.23M | -1,240.34%-893.73M |
| Less:Minority Profit | -7.22%-3.49M | 14.94%-12.22M | -21.99%-9.91M | 12.35%-6.11M | -78.67%-3.26M | -101.41%-14.37M | 4.47%-8.12M | -56.02%-6.97M | 23.26%-1.82M | -234.47%-7.13M |
| Net profit of parent company owners | 112.62%17.97M | 30.20%-440.63M | 48.15%-275.41M | 37.98%-261.84M | -1,047.82%-142.4M | 28.80%-631.26M | 36.32%-531.17M | 4.34%-422.21M | 89.51%-12.41M | -1,273.58%-886.59M |
| Earning per share | ||||||||||
| Basic earning per share | 112.50%0.01 | 29.73%-0.26 | 48.39%-0.16 | 36.00%-0.16 | -700.00%-0.08 | 38.33%-0.37 | 47.46%-0.31 | 19.35%-0.25 | 87.50%-0.01 | -1,100.00%-0.6 |
| Diluted earning per share | 112.50%0.01 | 29.73%-0.26 | 48.39%-0.16 | 36.00%-0.16 | -700.00%-0.08 | 38.33%-0.37 | 47.46%-0.31 | 19.35%-0.25 | 87.50%-0.01 | -1,100.00%-0.6 |
| Other composite income | -163.39%-6.63M | -46.49%60.76M | -130.40%-61.32M | -84.45%36.33M | 112.12%10.45M | -73.56%113.54M | -64.19%201.69M | -2.08%233.69M | -321.00%-86.27M | 580.08%429.45M |
| Other composite income of parent company owners | -163.39%-6.63M | -46.49%60.76M | -130.40%-61.32M | -84.45%36.33M | 112.12%10.45M | -73.56%113.54M | -64.19%201.69M | -2.08%233.69M | -321.00%-86.27M | 580.08%429.45M |
| Total composite income | 105.81%7.85M | 26.31%-392.09M | -2.68%-346.64M | -18.48%-231.62M | -34.53%-135.21M | -14.60%-532.09M | -20.79%-337.6M | 5.63%-195.49M | 28.78%-100.5M | -197.37%-464.28M |
| Total composite income of parent company owners | 108.60%11.34M | 26.63%-379.87M | -2.20%-336.73M | -19.62%-225.51M | -33.72%-131.95M | -13.25%-517.72M | -21.59%-329.48M | 6.99%-188.52M | 28.87%-98.68M | -196.85%-457.15M |
| Total composite income of minority owners | -7.22%-3.49M | 14.94%-12.22M | -21.99%-9.91M | 12.35%-6.11M | -78.67%-3.26M | -101.41%-14.37M | 4.47%-8.12M | -56.02%-6.97M | 23.26%-1.82M | -234.47%-7.13M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.